Statement Of Cash Flows [Abstract]

Innate Pharma - Filing #2816890

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income
367,000 EUR
962,000 EUR
Cash flows from (used in) operations before changes in working capital
48 573 EUR
2 562 EUR
Increase (decrease) in working capital
9 884 EUR
49 206 EUR
Adjustments for decrease (increase) in trade and other receivables
3 394 EUR
22 919 EUR
Adjustments for increase (decrease) in trade and other payables
946,000 EUR
6 528 EUR
Adjustments for increase (decrease) in employee benefit liabilities
437,000 EUR
216,000 EUR
Cash flows from (used in) investing activities [abstract]
Purchase of financial instruments, classified as investing activities
EUR
3 000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.